RARE - Financial Reports List - Ultragenyx Pharmaceutical Inc. - IntrinsicAlpha

Ultragenyx Pharmaceutical Inc. RARE

Healthcare - Biotechnology - NASDAQ - US

$ 32.14

-0.894 %

$ 3.02 B

Market Cap

-5.11

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	29.42%	-8.28%	-0.19%
Annual Report	FY	10-K	2024-12-31	29.01%	6.17%	5.84%
Quarterly Report	Q3	8-K	2024-09-30	42.27%	16.37%	9.04%
Quarterly Report	Q2	8-K	2024-06-30	35.75%	17.66%	21.35%
Quarterly Report	Q1	8-K	2024-03-31	8.30%	-4.09%	-7.30%
Quarterly Report	Q4	8-K	2023-12-31	23.27%	18.86%	16.19%
Annual Report	FY	10-K	2023-12-31	19.52%	14.25%	12.28%
Quarterly Report	Q3	8-K	2023-09-30	8.10%	34.87%	35.53%
Quarterly Report	Q2	8-K	2023-06-30	21.23%	-1.05%	-4.49%
Quarterly Report	Q1	8-K	2023-03-31	25.72%	-7.65%	-12.79%

1